Recent News

• 12.10.2025 - NeoGenomics to Present New ctDNA Research at SABCS 2025
• 12.08.2025 - NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025
• 11.06.2025 - NeoGenomics to Participate in Upcoming Investor Conferences
• 10.30.2025 - NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
• 10.28.2025 - NeoGenomics Reports Third Quarter 2025 Results
• 10.14.2025 - NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025
• 10.07.2025 - NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025

Recent Filings

• 12.09.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.09.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 12.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.02.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 11.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.25.2025 - 144 Report of proposed sale of securities
• 10.28.2025 - 8-K Current report
• 10.28.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 10.28.2025 - EX-99.1 EX-99.1
• 10.20.2025 - 4 Statement of changes in beneficial ownership of securities